James Yan
Chief Tech/Sci/R&D Officer en ZAI LAB LIMITED .
Cargos activos de James Yan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZAI LAB LIMITED | Chief Tech/Sci/R&D Officer | 01/04/2020 | - |
| Chinese Society of Toxicology | Corporate Officer/Principal | - | - |
Historial de carrera de James Yan
Antiguos cargos conocidos de James Yan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Formación de James Yan.
| Peking Union Medical College | Doctorate Degree |
Estadísticas
Internacional
| China | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Chinese Society of Toxicology |
- Bolsa de valores
- Insiders
- James Yan
- Experiencia
